Competitive Landscape Evaluation for Small Molecule Inhibitor Program
Issue: The VP of Research wanted to evaluate the commercial potential and competitive landscape for small molecule inhibitors of a T-cell kinase for treatment of ... [Read More]
Nerac Provides Clinical Trial and Post-Approval Surveillance Support
Issue: A client company had initiated a clinical program to test a previously-marketed drug for several new indications. The VP of R&D, aware of the ... [Read More]
Nerac Identifies List of Potential Acquirers and/or Licensees of Specific IP for Biotech Co.
Issue: The CSO of a biotechnology company was seeking potential acquirers or licensees of intellectual property rights to certain molecular targets and ... [Read More]
Nerac Identifies Reformulation Opportunity in Insomnia Market
Issue: The VP of R&D of a client company had information that a particular subset of the insomnia market was underserved by current available therapies. He ... [Read More]
Early Stage Clearance and Exclusivity Research for Global Pharmaceutical Co.
Issue: An experienced IP attorney at the US division of a global pharmaceutical company requested early-stage clearance and exclusivity research for biotherapies ... [Read More]
Nerac Assists Water Treatment Co. with R&D Decision
Issue: A Lead Development Engineer at a water treatment company needed assistance on whether or not to initiate internal R&D on a potentially emerging ... [Read More]
